44 results about "Prucalopride" patented technology

Prucalopride, brand name Prudac, among others, is a drug acting as a selective, high affinity 5-HT₄ receptor agonist which targets the impaired motility associated with chronic constipation, thus normalizing bowel movements. Prucalopride was approved for use in Europe in 2009, in Canada in 2011 and in Israel in 2014 but has only been recently approved by the Food and Drug Administration for use in the United States. The drug has also been tested for the treatment of chronic intestinal pseudo-obstruction.